NIMODIPINE

NIMODIPINE was reported 1122 times

NIMODIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAMILIAL HEMIPLEGIC MIGRAINE 1 0.2000
1 STOMA SITE POLYP 2 0.1818
2 THUNDERCLAP HEADACHE 12 0.0458
3 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 14 0.0368
4 ALCOHOL USE DISORDER 6 0.0351
5 CEREBRAL SALT-WASTING SYNDROME 3 0.0303
6 SUBCLAVIAN ARTERY OCCLUSION 3 0.0297
7 PREMATURE RECOVERY FROM ANAESTHESIA 1 0.0278
8 END-TIDAL CO2 INCREASED 1 0.0217
9 CLINICAL DEATH 1 0.0192
10 GAUCHER'S DISEASE 1 0.0182
11 DECEREBRATION 2 0.0175
12 CORTICAL DYSPLASIA 1 0.0169
13 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 31 0.0157
14 MIXED DEMENTIA 1 0.0156
15 CEREBROVASCULAR SPASM 2 0.0152
16 MYOCARDIAL STUNNING 2 0.0149
17 CEREBRAL VASOCONSTRICTION 10 0.0135
18 ANTICHOLINERGIC EFFECT 1 0.0133
19 RED BLOOD CELLS CSF POSITIVE 1 0.0130
20 VASOPLEGIA SYNDROME 21 0.0128
21 ABORTION MISSED 14 0.0110
22 ELECTROCARDIOGRAM PQ INTERVAL PROLONGED 1 0.0108
23 CONGENITAL PNEUMONIA 1 0.0105
24 PITUITARY CYST 1 0.0090
25 ONYCHOMALACIA 1 0.0080
26 VASOSPASM 7 0.0076
27 HISTIOCYTOSIS 1 0.0075
28 MIXED LIVER INJURY 22 0.0073
29 BLADDER NECK OBSTRUCTION 1 0.0073
30 GASTRITIS ATROPHIC 1 0.0066
31 TRANSFUSION-RELATED ACUTE LUNG INJURY 2 0.0065
32 MINERAL METABOLISM DISORDER 1 0.0063
33 LIVER SCAN ABNORMAL 1 0.0061
34 LARGE INTESTINAL POLYPECTOMY 1 0.0061
35 ALCOHOL ABUSE 16 0.0060
36 DIASTOLIC HYPOTENSION 1 0.0059
37 VASOGENIC CEREBRAL OEDEMA 4 0.0056
38 INTRACRANIAL HAEMATOMA 3 0.0053
39 ORGANIC BRAIN SYNDROME 1 0.0053
40 PATENT DUCTUS ARTERIOSUS 21 0.0053
41 CEREBRAL ISCHAEMIA 26 0.0050
42 NEUTROPHIL COUNT 1 0.0048
43 DYSBACTERIOSIS 1 0.0047
44 EMPTY SELLA SYNDROME 1 0.0046
45 HYPERLACTACIDAEMIA 12 0.0045
46 CRANIAL NERVE PARALYSIS 2 0.0042
47 BREATHING-RELATED SLEEP DISORDER 1 0.0042
48 SUBARACHNOID HAEMORRHAGE 43 0.0042
49 APALLIC SYNDROME 3 0.0041
50 DYSCALCULIA 1 0.0040
51 MENINGORRHAGIA 1 0.0040
52 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 3 0.0040
53 ACETONAEMIA 1 0.0040
54 MEAN ARTERIAL PRESSURE DECREASED 1 0.0040
55 MYOCARDIAL DEPRESSION 1 0.0039
56 EYELID CYST 1 0.0039
57 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
58 CSF PRESSURE INCREASED 1 0.0038
59 PERIPHERAL PARALYSIS 1 0.0037
60 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
61 CEREBRAL VENTRICLE DILATATION 4 0.0035
62 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
63 ERYTHEMA ANNULARE 1 0.0034
64 OXYGEN CONSUMPTION DECREASED 2 0.0033
65 HUMAN HERPESVIRUS 8 INFECTION 2 0.0033
66 GASTRIC HYPOMOTILITY 1 0.0033
67 RUPTURED CEREBRAL ANEURYSM 2 0.0031
68 CNS VENTRICULITIS 1 0.0031
69 NEPHROSTOMY 1 0.0030
70 HEMIPLEGIC MIGRAINE 1 0.0029
71 CHOLURIA 1 0.0029
72 PNEUMONITIS ASPIRATION 1 0.0029
73 PROPOFOL INFUSION SYNDROME 2 0.0028
74 FOREIGN BODY ASPIRATION 2 0.0028
75 ORAL DISCHARGE 1 0.0027
76 KERATOCONJUNCTIVITIS SICCA 1 0.0027
77 CORNEAL REFLEX DECREASED 1 0.0027
78 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
79 HYPOGLYCAEMIC ENCEPHALOPATHY 1 0.0026
80 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 1 0.0025
81 OPISTHOTONUS 2 0.0025
82 INTRACRANIAL ANEURYSM 10 0.0025
83 CRANIOTOMY 1 0.0024
84 BEHAVIOUR DISORDER 13 0.0024
85 BRAIN HERNIATION 7 0.0023
86 NODAL ARRHYTHMIA 2 0.0023
87 MOUTH BREATHING 1 0.0023
88 HYPERLEUKOCYTOSIS 2 0.0023
89 PNEUMATOSIS 1 0.0022
90 OPERATIVE HAEMORRHAGE 1 0.0022
91 BRAIN INJURY 22 0.0022
92 ANEURYSM RUPTURED 2 0.0022
93 SINUS BRADYCARDIA 21 0.0022
94 HYPERTRANSAMINASAEMIA 15 0.0022
95 MENINGISM 1 0.0021
96 PULMONARY VASCULAR DISORDER 1 0.0021
97 TELANGIECTASIA 2 0.0021
98 AMNESTIC DISORDER 1 0.0021
99 ENCEPHALITIS HERPES 1 0.0020
100 CSF TEST ABNORMAL 1 0.0020
101 PLEURAL FIBROSIS 2 0.0020
102 HYPERLIPASAEMIA 1 0.0019
103 CARDIOGENIC SHOCK 27 0.0019
104 VASCULAR CALCIFICATION 2 0.0019
105 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
106 BLOOD GASES ABNORMAL 1 0.0019
107 HYDROCEPHALUS 10 0.0018
108 HAEMORRHAGIC INFARCTION 1 0.0018
109 DYSPRAXIA 1 0.0018
110 ENTERAL NUTRITION 1 0.0017
111 POLYNEUROPATHY 20 0.0017
112 MONOPLEGIA 7 0.0016
113 DRUG LEVEL CHANGED 1 0.0016
114 ARTERITIS 1 0.0016
115 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
116 HYPERCHLORAEMIA 1 0.0016
117 CHORIORETINITIS 1 0.0016
118 INTRACRANIAL HYPOTENSION 1 0.0015
119 HYPERMAGNESAEMIA 1 0.0015
120 ORAL MUCOSAL DISCOLOURATION 1 0.0015
121 EFFUSION 2 0.0015
122 PLEURAL THICKENING 1 0.0015
123 OPHTHALMIC MIGRAINE 1 0.0014
124 INTRACRANIAL PRESSURE INCREASED 8 0.0014
125 FOREARM FRACTURE 1 0.0014
126 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
127 GRANULOMATOUS LIVER DISEASE 1 0.0014
128 INFANTILE SPASMS 1 0.0014
129 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
130 PULMONARY SEPSIS 2 0.0014
131 HEMIANOPIA HOMONYMOUS 1 0.0014
132 DRUG-DISEASE INTERACTION 1 0.0014
133 FINGER AMPUTATION 1 0.0014
134 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
135 ARTERIAL INJURY 1 0.0013
136 MYELOFIBROSIS 4 0.0013
137 CAUDA EQUINA SYNDROME 1 0.0013
138 ALLERGIC COUGH 1 0.0013
139 CRITICAL ILLNESS 1 0.0013
140 INFECTION PARASITIC 1 0.0013
141 BRAIN OEDEMA 16 0.0013
142 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
143 HAPTOGLOBIN DECREASED 1 0.0012
144 ENTEROCOCCAL SEPSIS 1 0.0012
145 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
146 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
147 DYSBIOSIS 1 0.0012
148 SELF-MEDICATION 5 0.0012
149 LINEAR IGA DISEASE 2 0.0012
150 DEMENTIA ALZHEIMER'S TYPE 2 0.0012
151 TONSILLAR HYPERTROPHY 2 0.0012
152 PROCEDURAL HYPOTENSION 1 0.0012
153 GAZE PALSY 2 0.0012
154 MEDICATION OVERUSE HEADACHE 1 0.0012
155 HEPATITIS CHOLESTATIC 7 0.0012
156 HEPATITIS TOXIC 3 0.0012
157 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
158 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
159 NUCHAL RIGIDITY 1 0.0011
160 CATARRH 1 0.0011
161 MONOPARESIS 2 0.0011
162 MUCOSAL EROSION 1 0.0011
163 PRURIGO 1 0.0011
164 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
165 BLOOD IRON INCREASED 2 0.0011
166 INTRACRANIAL MASS 1 0.0011
167 CHOLESTASIS 20 0.0010
168 PROSTATE INFECTION 1 0.0010
169 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
170 LUNG INFILTRATION 9 0.0010
171 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
172 HEMIANOPIA 1 0.0010
173 MUCOSAL DISORDER 1 0.0010
174 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
175 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
176 ANTISOCIAL BEHAVIOUR 1 0.0010
177 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
178 HEMIPLEGIA 8 0.0010
179 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
180 HYPOPERFUSION 1 0.0010
181 CEREBRAL ARTERY OCCLUSION 1 0.0009
182 FACIAL PALSY 2 0.0009
183 POST PROCEDURAL SWELLING 1 0.0009
184 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
185 DEMENTIA WITH LEWY BODIES 1 0.0009
186 HAEMORRHAGIC STROKE 7 0.0009
187 DISTRIBUTIVE SHOCK 2 0.0009
188 INFARCTION 6 0.0009
189 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
190 NEUROLOGICAL DECOMPENSATION 2 0.0009
191 CAROTID ARTERY STENOSIS 3 0.0009
192 HYPERTENSIVE EMERGENCY 1 0.0008
193 DEVICE DISPENSING ERROR 1 0.0008
194 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
195 MULTIMORBIDITY 1 0.0008
196 LACTIC ACIDOSIS 27 0.0008
197 EMBOLISM ARTERIAL 1 0.0008
198 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
199 CEREBRAL ARTERY EMBOLISM 1 0.0008
200 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
201 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
202 GASTROINTESTINAL TUBE INSERTION 2 0.0008
203 RENAL ATROPHY 1 0.0008
204 TUBERCULIN TEST POSITIVE 2 0.0008
205 APPLICATION SITE WARMTH 1 0.0008
206 BLOOD LACTIC ACID INCREASED 4 0.0008
207 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
208 AREFLEXIA 2 0.0007
209 MUSCLE HAEMORRHAGE 3 0.0007
210 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
211 GASTRIC PERFORATION 2 0.0007
212 SUBDURAL HAEMORRHAGE 2 0.0007
213 PREMATURE BABY 22 0.0007
214 CORNEAL ABRASION 1 0.0007
215 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
216 CULTURE URINE POSITIVE 1 0.0007
217 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
218 BLOOD ELECTROLYTES DECREASED 1 0.0007
219 IMPAIRED WORK ABILITY 15 0.0007
220 INVESTIGATION ABNORMAL 1 0.0007
221 CEREBRAL INFARCTION 17 0.0007
222 JUDGEMENT IMPAIRED 1 0.0007
223 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
224 NODAL RHYTHM 1 0.0007
225 HYPERTHERMIA MALIGNANT 1 0.0007
226 PITUITARY TUMOUR 1 0.0007
227 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
228 CEREBROVASCULAR DISORDER 2 0.0007
229 MOUTH INJURY 1 0.0007
230 HAEMODYNAMIC INSTABILITY 5 0.0007
231 ISCHAEMIA 3 0.0007
232 ORAL MUCOSAL ERUPTION 1 0.0007
233 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
234 HUMERUS FRACTURE 3 0.0006
235 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
236 ISCHAEMIC STROKE 11 0.0006
237 HYPERAMMONAEMIA 3 0.0006
238 CEREBRAL HAEMATOMA 2 0.0006
239 CARDIOVASCULAR DISORDER 15 0.0006
240 HEMIPARESIS 10 0.0006
241 BILIARY DYSKINESIA 1 0.0006
242 FOOD AVERSION 1 0.0006
243 FACIAL PARALYSIS 5 0.0006
244 LAZINESS 1 0.0006
245 BLOOD AMYLASE INCREASED 1 0.0006
246 INJECTION SITE OEDEMA 1 0.0006
247 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
248 BREAST CYST 1 0.0006
249 LIVER TRANSPLANT REJECTION 1 0.0006
250 ASTHMATIC CRISIS 2 0.0005
251 NERVOUS SYSTEM DISORDER 17 0.0005
252 PNEUMONIA KLEBSIELLA 1 0.0005
253 HEART RATE ABNORMAL 3 0.0005
254 COGNITIVE DISORDER 25 0.0005
255 FISTULA 6 0.0005
256 ARTERIAL DISORDER 1 0.0005
257 STRESS CARDIOMYOPATHY 3 0.0005
258 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
259 PURULENCE 1 0.0005
260 CONCOMITANT DISEASE PROGRESSION 1 0.0005
261 TORSADE DE POINTES 4 0.0005
262 COLOSTOMY 1 0.0005
263 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
264 DIPLEGIA 1 0.0005
265 CEREBRAL ATROPHY 2 0.0005
266 MUSCLE CONTRACTURE 1 0.0005
267 MOTOR DYSFUNCTION 5 0.0005
268 BREAST DISORDER 1 0.0005
269 QUADRIPLEGIA 1 0.0005
270 POLYCYTHAEMIA 1 0.0005
271 EAR SWELLING 1 0.0005
272 LIP OEDEMA 2 0.0005
273 ANAEMIA MACROCYTIC 1 0.0005
274 EXOPHTHALMOS 1 0.0005
275 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
276 LANGUAGE DISORDER 1 0.0005
277 PERIODONTITIS 1 0.0005
278 OLIGOMENORRHOEA 1 0.0005
279 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
280 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
281 MENINGITIS 3 0.0004
282 PARESIS 1 0.0004
283 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
284 INFECTIOUS MONONUCLEOSIS 1 0.0004
285 FEAR OF DEATH 1 0.0004
286 GINGIVAL BLEEDING 6 0.0004
287 ECCHYMOSIS 3 0.0004
288 DISEASE COMPLICATION 2 0.0004
289 DENGUE FEVER 1 0.0004
290 EYELID OEDEMA 5 0.0004
291 BILIRUBIN CONJUGATED INCREASED 1 0.0004
292 YELLOW SKIN 2 0.0004
293 PULMONARY TOXICITY 3 0.0004
294 LONG QT SYNDROME 1 0.0004
295 DIABETES INSIPIDUS 1 0.0004
296 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
297 PARKINSONISM 4 0.0004
298 BRONCHITIS CHRONIC 1 0.0004
299 ACUTE MYOCARDIAL INFARCTION 12 0.0004
300 INTENTIONAL OVERDOSE 26 0.0004
301 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
302 ANEURYSM 2 0.0004
303 EYELID IRRITATION 1 0.0004
304 LABYRINTHITIS 1 0.0004
305 TOXIC ENCEPHALOPATHY 2 0.0004
306 AORTIC ANEURYSM 3 0.0004
307 PARKINSON'S DISEASE 1 0.0004
308 CEREBRAL HAEMORRHAGE 14 0.0004
309 ATRIOVENTRICULAR BLOCK 3 0.0004
310 PETECHIAE 4 0.0004
311 SEDATION 10 0.0004
312 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
313 AGRANULOCYTOSIS 7 0.0004
314 ASPHYXIA 3 0.0004
315 JAW DISORDER 2 0.0004
316 APHASIA 11 0.0004
317 RASH MORBILLIFORM 1 0.0004
318 RASH MACULO-PAPULAR 8 0.0004
319 STATUS EPILEPTICUS 4 0.0004
320 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
321 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
322 HYPERTONIA 2 0.0003
323 HEAD INJURY 11 0.0003
324 HERPES VIRUS INFECTION 2 0.0003
325 PARAPLEGIA 1 0.0003
326 ESCHERICHIA SEPSIS 1 0.0003
327 HAEMOTHORAX 1 0.0003
328 METABOLIC ACIDOSIS 11 0.0003
329 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
330 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
331 DECREASED INTEREST 2 0.0003
332 CARDIOMYOPATHY 5 0.0003
333 BLOOD CULTURE POSITIVE 1 0.0003
334 HYPERCAPNIA 1 0.0003
335 BONE MARROW DISORDER 1 0.0003
336 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
337 CRANIOCEREBRAL INJURY 1 0.0003
338 EYE INJURY 1 0.0003
339 DYSAESTHESIA 1 0.0003
340 CHEST X-RAY ABNORMAL 1 0.0003
341 FIBROSIS 1 0.0003
342 GRAND MAL CONVULSION 3 0.0003
343 DEVICE RELATED INFECTION 5 0.0003
344 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
345 BRAIN DEATH 1 0.0003
346 PRODUCT DISTRIBUTION ISSUE 3 0.0003
347 FAMILY STRESS 1 0.0003
348 STEVENS-JOHNSON SYNDROME 7 0.0003
349 HEPATITIS ACUTE 2 0.0003
350 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
351 SHOCK 7 0.0003
352 LISTLESS 1 0.0003
353 PRODUCT LABEL ISSUE 2 0.0003
354 DIABETIC RETINOPATHY 1 0.0003
355 HYPOTENSION 59 0.0003
356 BRONCHOPNEUMONIA 1 0.0003
357 RESPIRATORY DISTRESS 8 0.0003
358 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
359 ENCEPHALITIS 2 0.0003
360 GRANULOMA 1 0.0003
361 HYPERREFLEXIA 1 0.0003
362 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
363 SUDDEN DEATH 3 0.0003
364 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
365 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
366 HEPATOCELLULAR INJURY 4 0.0003
367 CONJUNCTIVAL HYPERAEMIA 1 0.0003
368 RENAL TRANSPLANT 1 0.0003
369 VISUAL FIELD DEFECT 2 0.0003
370 RASH PUSTULAR 2 0.0003
371 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
372 AMYLASE INCREASED 1 0.0003
373 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
374 NEUTROPHIL COUNT DECREASED 11 0.0003
375 URINARY RETENTION 9 0.0003
376 CARDIAC DYSFUNCTION 1 0.0003
377 HYPERACUSIS 1 0.0003
378 HEPATIC NECROSIS 1 0.0003
379 CATHETER SITE INFECTION 1 0.0003
380 FACE INJURY 1 0.0003
381 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
382 COMMUNICATION DISORDER 1 0.0003
383 LIPASE INCREASED 2 0.0003
384 PROCEDURAL COMPLICATION 2 0.0003
385 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
386 ELECTROLYTE IMBALANCE 3 0.0003
387 PANIC DISORDER 1 0.0003
388 CAESAREAN SECTION 3 0.0003
389 APNOEA 2 0.0003
390 CARDIOPULMONARY FAILURE 1 0.0003
391 SPINAL PAIN 3 0.0003
392 PROSTATOMEGALY 1 0.0003
393 MENTAL STATUS CHANGES 7 0.0003
394 COMA 12 0.0003
395 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
396 LOW BIRTH WEIGHT BABY 2 0.0003
397 ATRIAL FLUTTER 2 0.0003
398 WRIST FRACTURE 3 0.0003
399 SENSORY LOSS 2 0.0002
400 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
401 NO THERAPEUTIC RESPONSE 3 0.0002
402 BRADYCARDIA 13 0.0002
403 POLYURIA 2 0.0002
404 DEMYELINATION 1 0.0002
405 HICCUPS 2 0.0002
406 HYPERURICAEMIA 1 0.0002
407 OSTEONECROSIS OF JAW 6 0.0002
408 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
409 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
410 EOSINOPHIL COUNT INCREASED 2 0.0002
411 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
412 FACE OEDEMA 4 0.0002
413 AORTIC VALVE INCOMPETENCE 1 0.0002
414 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
415 POOR PERIPHERAL CIRCULATION 1 0.0002
416 ROTATOR CUFF SYNDROME 3 0.0002
417 RENAL FAILURE 31 0.0002
418 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
419 MULTI-ORGAN FAILURE 4 0.0002
420 CARDIAC MURMUR 2 0.0002
421 HORDEOLUM 1 0.0002
422 OCULAR ICTERUS 1 0.0002
423 PARONYCHIA 1 0.0002
424 HEAD DISCOMFORT 4 0.0002
425 BLOOD CREATINE INCREASED 1 0.0002
426 PULMONARY OEDEMA 10 0.0002
427 LEUKOCYTOSIS 4 0.0002
428 OPTIC NEURITIS 2 0.0002
429 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
430 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
431 FEELING OF DESPAIR 1 0.0002
432 HEPATIC ENCEPHALOPATHY 2 0.0002
433 BLINDNESS UNILATERAL 3 0.0002
434 GASTRIC ULCER 4 0.0002
435 PRE-ECLAMPSIA 1 0.0002
436 PULSE ABSENT 1 0.0002
437 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
438 ATELECTASIS 2 0.0002
439 FLUID OVERLOAD 3 0.0002
440 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
441 HORMONE LEVEL ABNORMAL 1 0.0002
442 HEPATOMEGALY 2 0.0002
443 APPLICATION SITE BURN 1 0.0002
444 BREATH SOUNDS ABNORMAL 1 0.0002
445 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
446 DISORIENTATION 8 0.0002
447 DRUG INTERACTION 32 0.0002
448 TOXICITY TO VARIOUS AGENTS 34 0.0002
449 BLADDER DISORDER 2 0.0002
450 HYPOTONIA 2 0.0002
451 THERAPY NON-RESPONDER 9 0.0002
452 DERMATITIS EXFOLIATIVE 1 0.0002
453 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
454 DRUG DISPENSING ERROR 3 0.0002
455 AMMONIA INCREASED 1 0.0002
456 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
457 NEUTROPHIL COUNT INCREASED 2 0.0002
458 ENDOCARDITIS 1 0.0002
459 EXPOSURE DURING PREGNANCY 12 0.0002
460 DRUG-INDUCED LIVER INJURY 6 0.0002
461 PARTIAL SEIZURES 1 0.0002
462 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
463 PREMATURE DELIVERY 3 0.0002
464 OVERWEIGHT 1 0.0002
465 MUSCLE TIGHTNESS 3 0.0002
466 PRURITUS GENERALISED 4 0.0002
467 OESOPHAGITIS 2 0.0002
468 WOUND INFECTION 2 0.0002
469 AUTISM SPECTRUM DISORDER 1 0.0002
470 DEAFNESS UNILATERAL 1 0.0002
471 CHOKING SENSATION 1 0.0002
472 PROSTATIC DISORDER 1 0.0002
473 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
474 FEELING COLD 5 0.0002
475 ANGIOPATHY 1 0.0002
476 MACULAR OEDEMA 1 0.0002
477 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
478 RESPIRATORY FAILURE 13 0.0002
479 ACUTE PULMONARY OEDEMA 1 0.0002
480 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
481 CHOLECYSTITIS ACUTE 1 0.0002
482 CIRCULATORY COLLAPSE 3 0.0002
483 PERONEAL NERVE PALSY 1 0.0002
484 NEUROLOGICAL SYMPTOM 1 0.0002
485 DELIRIUM 6 0.0002
486 EOSINOPHILIA 3 0.0002
487 COVID-19 PNEUMONIA 2 0.0002
488 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
489 ATAXIA 2 0.0002
490 CHOLECYSTITIS 2 0.0002
491 CARDIAC PACEMAKER INSERTION 1 0.0002
492 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
493 BLOOD PRESSURE DECREASED 11 0.0002
494 PLATELET COUNT ABNORMAL 1 0.0002
495 HYPERGLYCAEMIA 6 0.0002
496 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
497 LARYNGEAL OEDEMA 1 0.0002
498 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
499 PIGMENTATION DISORDER 1 0.0002
500 GENERALISED OEDEMA 2 0.0002
501 HEPATIC FUNCTION ABNORMAL 6 0.0002
502 SYNCOPE 16 0.0002
503 DYSARTHRIA 6 0.0002
504 DERMATITIS ALLERGIC 2 0.0002
505 HYPOCALCAEMIA 3 0.0002
506 SLEEP APNOEA SYNDROME 3 0.0002
507 PULMONARY FIBROSIS 3 0.0002
508 MOVEMENT DISORDER 5 0.0002
509 HAEMOGLOBIN ABNORMAL 1 0.0002
510 ANOREXIA 2 0.0002
511 CONFUSIONAL STATE 25 0.0002
512 INCOHERENT 1 0.0002
513 HERPES SIMPLEX 1 0.0002
514 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
515 PLATELET COUNT INCREASED 2 0.0002
516 BRADYPHRENIA 1 0.0002
517 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
518 BREAST MASS 1 0.0001
519 BRONCHIECTASIS 1 0.0001
520 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
521 IMPAIRED GASTRIC EMPTYING 2 0.0001
522 HAEMOGLOBIN DECREASED 15 0.0001
523 LYMPHOEDEMA 1 0.0001
524 LARGE INTESTINE POLYP 1 0.0001
525 COORDINATION ABNORMAL 2 0.0001
526 EXTRASYSTOLES 1 0.0001
527 DUODENAL ULCER 1 0.0001
528 CEREBROVASCULAR ACCIDENT 24 0.0001
529 HAND FRACTURE 1 0.0001
530 DIALYSIS 2 0.0001
531 FEAR OF INJECTION 1 0.0001
532 LEUKOPENIA 7 0.0001
533 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
534 LETHARGY 8 0.0001
535 INJECTION SITE HAEMATOMA 2 0.0001
536 HYPOKINESIA 2 0.0001
537 PRODUCT DISPENSING ERROR 3 0.0001
538 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
539 LIVER FUNCTION TEST ABNORMAL 4 0.0001
540 FAECES SOFT 1 0.0001
541 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
542 MOUTH HAEMORRHAGE 1 0.0001
543 RASH PAPULAR 3 0.0001
544 CHROMATURIA 3 0.0001
545 ACIDOSIS 1 0.0001
546 BOWEL MOVEMENT IRREGULARITY 1 0.0001
547 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
548 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
549 RENAL DISORDER 6 0.0001
550 PULMONARY HAEMORRHAGE 1 0.0001
551 ARRHYTHMIA 6 0.0001
552 BLOOD PRESSURE FLUCTUATION 3 0.0001
553 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
554 MUSCLE DISORDER 1 0.0001
555 FLATULENCE 7 0.0001
556 DYSKINESIA 5 0.0001
557 BACK DISORDER 2 0.0001
558 CONVULSION 7 0.0001
559 HYPERAESTHESIA 1 0.0001
560 EYE DISORDER 4 0.0001
561 ABASIA 3 0.0001
562 SEIZURE 14 0.0001
563 PHOTOSENSITIVITY REACTION 2 0.0001
564 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
565 DRUG LEVEL INCREASED 2 0.0001
566 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
567 ACUTE CORONARY SYNDROME 1 0.0001
568 EMBOLISM 1 0.0001
569 PNEUMONIA ASPIRATION 3 0.0001
570 COAGULOPATHY 2 0.0001
571 RHABDOMYOLYSIS 5 0.0001
572 LIVE BIRTH 1 0.0001
573 BLOOD UREA INCREASED 2 0.0001
574 HAEMODIALYSIS 1 0.0001
575 HYPOPHAGIA 3 0.0001
576 SCAR 2 0.0001
577 PRODUCT CONTAINER ISSUE 1 0.0001
578 INFLUENZA 13 0.0001
579 DEAFNESS 3 0.0001
580 SPEECH DISORDER 6 0.0001
581 HYPERKALAEMIA 4 0.0001
582 HYPOXIA 4 0.0001
583 COLD SWEAT 2 0.0001
584 HYPERTENSION 24 0.0001
585 DRUG ERUPTION 2 0.0001
586 CARDIOTOXICITY 1 0.0001
587 FACIAL PAIN 1 0.0001
588 FEAR 3 0.0001
589 CARDIAC ARREST 9 0.0001
590 AGITATION 8 0.0001
591 INCREASED TENDENCY TO BRUISE 1 0.0001
592 ANAPHYLACTIC REACTION 6 0.0001
593 IRON DEFICIENCY ANAEMIA 1 0.0001
594 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
595 COMPLETED SUICIDE 9 0.0001
596 WOUND 3 0.0001
597 BLOOD CREATININE INCREASED 7 0.0001
598 NEPHROPATHY 1 0.0001
599 PHOTOPHOBIA 2 0.0001
600 ARTERIOSCLEROSIS 1 0.0001
601 BLOOD SODIUM DECREASED 2 0.0001
602 FRACTURE 2 0.0001
603 EYE INFLAMMATION 1 0.0001
604 RASH ERYTHEMATOUS 5 0.0001
605 DRUG PRESCRIBING ERROR 2 0.0001
606 ACUTE RESPIRATORY FAILURE 2 0.0001
607 HERNIA 2 0.0001
608 EAR PAIN 2 0.0001
609 CHOKING 2 0.0001
610 PHARYNGEAL SWELLING 1 0.0001
611 RENAL TUBULAR NECROSIS 1 0.0001
612 LIGAMENT SPRAIN 1 0.0001
613 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
614 INABILITY TO AFFORD MEDICATION 1 0.0001
615 UPPER LIMB FRACTURE 2 0.0001
616 HEPATIC FAILURE 3 0.0001
617 EMPHYSEMA 1 0.0001
618 PRODUCT ADMINISTRATION ERROR 2 0.0001
619 VERTIGO 6 0.0001
620 EYELID PTOSIS 1 0.0001
621 DRY THROAT 1 0.0001
622 FLUID RETENTION 5 0.0001
623 EPILEPSY 3 0.0001
624 INITIAL INSOMNIA 1 0.0001
625 HYPERBILIRUBINAEMIA 1 0.0001
626 EYE DISCHARGE 1 0.0001
627 PRODUCT ODOUR ABNORMAL 1 0.0001
628 DERMATITIS 2 0.0001
629 CONDITION AGGRAVATED 29 0.0001
630 FOLLICULITIS 1 0.0001
631 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
632 DYSPHAGIA 9 0.0001
633 FULL BLOOD COUNT ABNORMAL 1 0.0001
634 RENAL PAIN 1 0.0001
635 RENAL FAILURE ACUTE 4 0.0001
636 HYPOTHYROIDISM 3 0.0001
637 BODY HEIGHT DECREASED 1 0.0001
638 BREAST CANCER METASTATIC 1 0.0001
639 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
640 AMNESIA 6 0.0001
641 BIPOLAR DISORDER 1 0.0001
642 SEPTIC SHOCK 4 0.0001
643 PRODUCT PRESCRIBING ISSUE 2 0.0001
644 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
645 ASPIRATION 1 0.0001
646 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
647 VISUAL ACUITY REDUCED 3 0.0001
648 MEDICATION ERROR 5 0.0001
649 TRANSAMINASES INCREASED 2 0.0001
650 HYPERTENSIVE CRISIS 1 0.0001
651 HEPATOTOXICITY 2 0.0001
652 SEPSIS 10 0.0001
653 SNEEZING 2 0.0001
654 REBOUND EFFECT 1 0.0001
655 MITRAL VALVE INCOMPETENCE 1 0.0001
656 CHOLECYSTECTOMY 1 0.0001
657 SKIN DISCOLOURATION 4 0.0001
658 OROPHARYNGEAL PAIN 8 0.0001
659 POST PROCEDURAL HAEMORRHAGE 1 0.0001
660 BLOOD CHOLESTEROL INCREASED 4 0.0001
661 DISEASE RECURRENCE 4 0.0001
662 MYOCLONUS 1 0.0001
663 MUSCLE RIGIDITY 1 0.0001
664 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
665 MENTAL IMPAIRMENT 2 0.0001
666 ADRENAL INSUFFICIENCY 1 0.0001
667 NOCTURIA 1 0.0001
668 NEURALGIA 2 0.0001
669 OFF LABEL USE 72 0.0001
670 RESTLESSNESS 3 0.0001
671 DISCOMFORT 5 0.0001
672 INJECTION SITE URTICARIA 2 0.0001
673 DYSURIA 3 0.0001
674 ENCEPHALOPATHY 2 0.0001
675 MUSCLE SPASTICITY 1 0.0001
676 CARDIOMEGALY 1 0.0001
677 HYPERCALCAEMIA 1 0.0001
678 NEUTROPENIA 11 0.0001
679 PHARYNGITIS 1 0.0001
680 THROMBOCYTOPENIA 9 0.0001
681 MUSCLE ATROPHY 1 0.0001
682 HAEMATEMESIS 2 0.0001
683 TACHYCARDIA 7 0.0001
684 DIABETES MELLITUS 6 0.0001
685 GAIT DISTURBANCE 15 0.0001
686 INTRAOCULAR PRESSURE INCREASED 1 0.0001
687 HEPATITIS 2 0.0001
688 PYREXIA 27 0.0001
689 MYDRIASIS 1 0.0001
690 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
691 SKIN ULCER 2 0.0001
692 RASH GENERALISED 2 0.0001
693 HAEMATOMA 2 0.0001
694 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
695 NERVOUSNESS 4 0.0001
696 INCORRECT PRODUCT STORAGE 1 0.0001
697 EYE HAEMORRHAGE 1 0.0001
698 PNEUMONIA 24 0.0001
699 BLOOD BILIRUBIN INCREASED 2 0.0001
700 PALLOR 2 0.0001
701 MOOD ALTERED 2 0.0001
702 ACUTE HEPATIC FAILURE 1 0.0001
703 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
704 CORONARY ARTERY OCCLUSION 1 0.0001
705 PERIPHERAL COLDNESS 1 0.0001
706 VISUAL IMPAIRMENT 9 0.0001
707 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
708 BLOOD PRESSURE INCREASED 11 0.0001
709 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
710 HUNGER 1 0.0001
711 NO ADVERSE EVENT 13 0.0001
712 CARDIO-RESPIRATORY ARREST 3 0.0001
713 APHONIA 1 0.0001
714 MASS 1 0.0001
715 BURNING SENSATION 5 0.0001
716 OXYGEN SATURATION DECREASED 4 0.0001
717 INJURY 5 0.0001
718 HYPONATRAEMIA 4 0.0001
719 OSTEOARTHRITIS 3 0.0001
720 BRONCHOSPASM 1 0.0001
721 RED BLOOD CELL COUNT DECREASED 2 0.0001
722 MYELODYSPLASTIC SYNDROME 1 0.0001
723 HYPERTHYROIDISM 1 0.0001
724 MENTAL DISORDER 3 0.0001
725 APATHY 1 0.0001
726 GASTROENTERITIS 1 0.0001
727 PAIN IN EXTREMITY 20 0.0001
728 PSYCHOTIC DISORDER 2 0.0001
729 DRUG INEFFECTIVE 89 0.0001
730 HAEMORRHAGE INTRACRANIAL 1 0.0001
731 RESPIRATORY DISORDER 2 0.0001
732 HALLUCINATION 5 0.0001
733 HYPOAESTHESIA ORAL 1 0.0001
734 LACRIMATION INCREASED 2 0.0001
735 DIZZINESS 33 0.0001
736 FALL 22 0.0001
737 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
738 OSTEOPENIA 1 0.0001
739 PLEURAL EFFUSION 4 0.0001
740 PLATELET COUNT DECREASED 7 0.0001
741 SKIN IRRITATION 3 0.0001
742 INSURANCE ISSUE 1 0.0001
743 TINNITUS 3 0.0001
744 HIP ARTHROPLASTY 1 0.0001
745 LYMPHOMA 1 0.0001
746 LIMB DISCOMFORT 2 0.0001
747 MUSCULOSKELETAL CHEST PAIN 1 0.0001
748 ANKLE FRACTURE 1 0.0001
749 SOMNOLENCE 13 0.0001
750 DELUSION 1 0.0001
751 EJECTION FRACTION DECREASED 1 0.0001
752 PNEUMOTHORAX 1 0.0001
753 RESPIRATORY TRACT CONGESTION 1 0.0001
754 HALLUCINATION, AUDITORY 1 0.0001
755 ANAEMIA 12 0.0001
756 PRODUCTIVE COUGH 3 0.0001
757 VOMITING 29 0.0001
758 MANIA 1 0.0001
759 VIRAL INFECTION 2 0.0001
760 DRUG ABUSE 5 0.0001
761 FUNGAL INFECTION 2 0.0001
762 RENAL IMPAIRMENT 5 0.0001
763 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
764 ANGER 2 0.0001
765 SINUSITIS 6 0.0001
766 PRODUCT USE ISSUE 11 0.0001
767 HAEMATURIA 2 0.0001
768 INFLAMMATION 3 0.0001
769 ABDOMINAL DISTENSION 6 0.0001
770 ORTHOSTATIC HYPOTENSION 1 0.0001
771 NEUROTOXICITY 1 0.0001
772 HEART RATE DECREASED 2 0.0001
773 PANCREATITIS 3 0.0001
774 GALLBLADDER DISORDER 1 0.0001
775 GASTROENTERITIS VIRAL 1 0.0001
776 RASH PRURITIC 3 0.0001
777 ARTHRALGIA 23 0.0001
778 PELVIC PAIN 1 0.0001
779 CRYING 2 0.0001
780 MALAISE 24 0.0001
781 ACCIDENTAL OVERDOSE 2 0.0001
782 LOSS OF CONSCIOUSNESS 7 0.0001
783 NECK PAIN 3 0.0001
784 SWELLING 5 0.0001
785 HEPATIC CIRRHOSIS 1 0.0001
786 ASTHENIA 20 0.0001
787 MUSCULAR WEAKNESS 6 0.0001
788 COLITIS 2 0.0001
789 BLOOD URINE PRESENT 1 0.0001
790 HEADACHE 33 0.0001
791 PULMONARY EMBOLISM 5 0.0001
792 MUSCULOSKELETAL DISORDER 1 0.0001
793 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
794 POST PROCEDURAL COMPLICATION 1 0.0001
795 GLAUCOMA 1 0.0001
796 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
797 PRESCRIBED OVERDOSE 1 0.0001
798 ABDOMINAL PAIN 12 0.0001
799 DYSTONIA 1 0.0001
800 ATRIAL FIBRILLATION 5 0.0001
801 BONE PAIN 3 0.0001
802 CHILLS 6 0.0001
803 SURGERY 3 0.0001
804 DIARRHOEA 33 0.0001
805 NASAL CONGESTION 3 0.0001
806 MEMORY IMPAIRMENT 7 0.0001
807 HAEMATOCRIT DECREASED 1 0.0001
808 BLOOD PRESSURE ABNORMAL 1 0.0001
809 COMPLICATION OF DEVICE INSERTION 1 0.0001
810 CYTOKINE RELEASE SYNDROME 1 0.0000
811 FULL BLOOD COUNT DECREASED 1 0.0000
812 PRODUCT PHYSICAL ISSUE 1 0.0000
813 STOMATITIS 3 0.0000
814 FEEDING DISORDER 1 0.0000
815 INJURY ASSOCIATED WITH DEVICE 1 0.0000
816 BODY TEMPERATURE INCREASED 1 0.0000
817 FEELING HOT 3 0.0000
818 PRODUCT PREPARATION ERROR 1 0.0000
819 OSTEOPOROSIS 2 0.0000
820 INTENTIONAL DRUG MISUSE 1 0.0000
821 HALLUCINATION, VISUAL 1 0.0000
822 EATING DISORDER 1 0.0000
823 URINARY TRACT INFECTION 8 0.0000
824 IRRITABLE BOWEL SYNDROME 1 0.0000
825 HYPOACUSIS 2 0.0000
826 BALANCE DISORDER 4 0.0000
827 FAECES DISCOLOURED 1 0.0000
828 SWELLING FACE 3 0.0000
829 MELAENA 1 0.0000
830 FEBRILE NEUTROPENIA 3 0.0000
831 ANGIOEDEMA 2 0.0000
832 COLITIS ULCERATIVE 2 0.0000
833 PANCREATITIS ACUTE 1 0.0000
834 PRODUCT AVAILABILITY ISSUE 1 0.0000
835 ERYTHEMA 9 0.0000
836 VISION BLURRED 6 0.0000
837 NEPHROLITHIASIS 2 0.0000
838 PERICARDIAL EFFUSION 1 0.0000
839 SLEEP DISORDER 3 0.0000
840 TREMOR 7 0.0000
841 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
842 OCULAR HYPERAEMIA 2 0.0000
843 PRODUCT PRESCRIBING ERROR 1 0.0000
844 DRUG INTOLERANCE 4 0.0000
845 RASH 18 0.0000
846 HYPOGLYCAEMIA 2 0.0000
847 FIBROMYALGIA 1 0.0000
848 PAIN 25 0.0000
849 MYOCARDIAL INFARCTION 7 0.0000
850 CELLULITIS 2 0.0000
851 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
852 ACUTE KIDNEY INJURY 6 0.0000
853 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
854 DRUG RESISTANCE 1 0.0000
855 ILLNESS 4 0.0000
856 ANAPHYLACTIC SHOCK 1 0.0000
857 BACK PAIN 9 0.0000
858 EXPOSURE VIA SKIN CONTACT 1 0.0000
859 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
860 HAEMORRHAGE 4 0.0000
861 MUSCLE SPASMS 7 0.0000
862 GASTRITIS 1 0.0000
863 DEPRESSED MOOD 2 0.0000
864 CHEST PAIN 7 0.0000
865 HYPERSENSITIVITY 7 0.0000
866 INSOMNIA 10 0.0000
867 DEHYDRATION 5 0.0000
868 JAUNDICE 1 0.0000
869 FREQUENT BOWEL MOVEMENTS 1 0.0000
870 LIMB INJURY 1 0.0000
871 RESPIRATORY ARREST 1 0.0000
872 ABNORMAL DREAMS 1 0.0000
873 PROCEDURAL PAIN 1 0.0000
874 ARTHROPATHY 2 0.0000
875 HAEMOPTYSIS 1 0.0000
876 COUGH 10 0.0000
877 BLISTER 2 0.0000
878 EYE PAIN 2 0.0000
879 INTENTIONAL DOSE OMISSION 1 0.0000
880 ANGINA PECTORIS 1 0.0000
881 PRODUCT SUBSTITUTION ISSUE 2 0.0000
882 MUSCULOSKELETAL STIFFNESS 3 0.0000
883 DISEASE PROGRESSION 4 0.0000
884 CATARACT 2 0.0000
885 CORONARY ARTERY DISEASE 1 0.0000
886 ILL-DEFINED DISORDER 2 0.0000
887 OEDEMA PERIPHERAL 4 0.0000
888 DRUG ADMINISTRATION ERROR 1 0.0000
889 EMOTIONAL DISORDER 1 0.0000
890 WEIGHT DECREASED 9 0.0000
891 BLOOD GLUCOSE INCREASED 6 0.0000
892 WEIGHT INCREASED 7 0.0000
893 CONTUSION 3 0.0000
894 HIP FRACTURE 1 0.0000
895 RHINORRHOEA 2 0.0000
896 DEEP VEIN THROMBOSIS 2 0.0000
897 DEPRESSION 7 0.0000
898 IMPAIRED HEALING 1 0.0000
899 OSTEONECROSIS 1 0.0000
900 HEART RATE INCREASED 3 0.0000
901 DECREASED APPETITE 7 0.0000
902 EXPIRED PRODUCT ADMINISTERED 1 0.0000
903 LIP SWELLING 1 0.0000
904 GAIT INABILITY 1 0.0000
905 URTICARIA 5 0.0000
906 PRODUCT QUALITY ISSUE 4 0.0000
907 HEPATIC ENZYME INCREASED 2 0.0000
908 GASTRIC DISORDER 1 0.0000
909 PRURITUS 11 0.0000
910 RASH MACULAR 1 0.0000
911 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
912 MOBILITY DECREASED 2 0.0000
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
914 INFECTION 4 0.0000
915 DRUG EFFECT INCOMPLETE 1 0.0000
916 PANIC ATTACK 1 0.0000
917 BRONCHITIS 2 0.0000
918 EYE SWELLING 1 0.0000
919 ASTHMA 3 0.0000
920 DYSPNOEA 15 0.0000
921 RHEUMATOID ARTHRITIS 3 0.0000
922 INCORRECT DOSE ADMINISTERED 6 0.0000
923 INJECTION SITE SWELLING 2 0.0000
924 PERIPHERAL SWELLING 4 0.0000
925 ARTHRITIS 2 0.0000
926 ABNORMAL BEHAVIOUR 1 0.0000
927 FEELING ABNORMAL 6 0.0000
928 CARDIAC FAILURE CONGESTIVE 2 0.0000
929 THROMBOSIS 2 0.0000
930 JOINT SWELLING 3 0.0000
931 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
932 EMOTIONAL DISTRESS 3 0.0000
933 PSORIATIC ARTHROPATHY 1 0.0000
934 ANXIETY 7 0.0000
935 BLINDNESS 1 0.0000
936 FATIGUE 19 0.0000
937 LUNG NEOPLASM MALIGNANT 1 0.0000
938 TREATMENT FAILURE 2 0.0000
939 NAUSEA 19 0.0000
940 POLLAKIURIA 1 0.0000
941 ABDOMINAL DISCOMFORT 4 0.0000
942 OVERDOSE 5 0.0000
943 CONSTIPATION 5 0.0000
944 INTENTIONAL PRODUCT MISUSE 2 0.0000
945 LIVER DISORDER 1 0.0000
946 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
947 NEUROPATHY PERIPHERAL 2 0.0000
948 MIGRAINE 2 0.0000
949 BLOOD GLUCOSE DECREASED 1 0.0000
950 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
951 INTERSTITIAL LUNG DISEASE 1 0.0000
952 HYPOAESTHESIA 3 0.0000
953 AGGRESSION 1 0.0000
954 FLUSHING 2 0.0000
955 CHEST DISCOMFORT 2 0.0000
956 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
957 MUSCULOSKELETAL PAIN 1 0.0000
958 PARAESTHESIA 3 0.0000
959 DERMATITIS ATOPIC 1 0.0000
960 DRUG EFFECT DECREASED 1 0.0000
961 OEDEMA 1 0.0000
962 EYE IRRITATION 1 0.0000
963 DYSPHONIA 1 0.0000
964 IRRITABILITY 1 0.0000
965 PRODUCT DOSE OMISSION 1 0.0000
966 ALOPECIA 3 0.0000
967 INFUSION RELATED REACTION 1 0.0000
968 ABDOMINAL PAIN UPPER 3 0.0000
969 DYSGEUSIA 1 0.0000
970 EPISTAXIS 1 0.0000
971 CHRONIC KIDNEY DISEASE 1 0.0000
972 HOSPITALISATION 2 0.0000
973 DEATH 11 0.0000
974 INJECTION SITE BRUISING 1 0.0000
975 CARDIAC FAILURE 1 0.0000
976 INFLUENZA LIKE ILLNESS 1 0.0000
977 MYALGIA 2 0.0000
978 COVID-19 2 0.0000
979 GASTROINTESTINAL DISORDER 1 0.0000
980 DEVICE ISSUE 1 0.0000
981 ADVERSE EVENT 1 0.0000
982 CARDIAC DISORDER 1 0.0000
983 PRODUCT DOSE OMISSION ISSUE 3 0.0000
984 DYSPEPSIA 1 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
987 PALPITATIONS 1 0.0000
988 INJECTION SITE ERYTHEMA 1 0.0000
989 HYPERHIDROSIS 1 0.0000
990 DRUG DEPENDENCE 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000
992 NASOPHARYNGITIS 1 0.0000
993 INJECTION SITE PAIN 1 0.0000